MIRA INFORM REPORT

 

 

Report No. :

494912

Report Date :

28.02.2018

 

 

 

 

Mob. No.:

0091 75749 96300

 

 

IDENTIFICATION DETAILS

 

Name :

KAISHA LIFESCIENCES PRIVATE LIMITED [w.e.f. 07.08.2014]

 

 

Formerly Known As :

SOVEREIGNTY PHARMA PRIVATE LIMITED

 

 

Registered Office :

70, Nagindas Master Road, Fort, Mumbai-400023, Maharashtra

Mob. No.:

91-7574996300 [Mr. Rishad Kairus Dadachanji]

 

 

Country :

India

 

 

Financials (as on) :

31.03.2016

 

 

Date of Incorporation :

06.07.2010

 

 

Com. Reg. No.:

11-205291

 

 

Capital Investment / Paid-up Capital :

INR 0.100 Million

 

 

CIN No.:

[Company Identification No.]

U74120MH2010PTC205291

 

 

IEC No.:

Not Divulged

 

 

GST No.:

Not Divulged

 

 

TIN No.:

Not Divulged

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

Not Available

 

 

PAN No.:

[Permanent Account No.]

AAOCS5727M

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturer and Trader of wide range of Pharmaceutical Products from Formulation and also Research and Development (R&P) activities in Lifesciences. [Registered Activity]

 

 

No. of Employees :

Information declined by the Management

 

 

RATING & COMMENTS

(Mira Inform has adopted New Rating mechanism w.e.f. 23rd January 2017)

 

MIRA’s Rating :

C

 

Credit Rating

Explanation

Rating Comments

C

Medium High Risk

Business dealings permissible preferably on secured basis

 

Status :

Yet to commence its business operations

 

 

Payment Behaviour :

Unknown

 

 

Litigation :

Clear

 

 

Comments :

Even though the company was incorporated in the year 2010, it is yet to commence with its commercial operations.

 

Management has failed to file its latest financials with Government Registry.

 

As per available financials of March 2016, the company some pre-operating expenses and incurred losses.

 

Rating takes into consideration the company’s previous year’s losses along with deteriorating financial risk profile and low liquidity position.

 

However, rating strength is partially offset by zero debt balance sheet of the company.

 

Payments are reported to be unknown.

 

In view of aforesaid, the company can be considered for business dealings at safe and secured trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

EXTERNAL AGENCY RATING

 

NOT AVAILABLE

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2016.

 

 

BIFR (Board for Industrial & Financial Reconstruction) LISTING STATUS

 

Subject’s name is not listed as a Sick Unit in the publicly available BIFR (Board for Industrial & Financial Reconstruction) list as of 28.02.2018.

 

 

IBBI (Insolvency and Bankruptcy Board of India) LISTING STATUS

 

Subject’s name is not listed in the publicly available IBBI (Insolvency and Bankruptcy Board of India) list as of report date.

 

 

INFORMATION DECLINED BY

 

Name :

Mr. Rishad Kairus Dadachanji

Designation :

Managing Director

Contact No.:

91-7574996300

Date :

27.02.2018

 

 

LOCATIONS

 

Registered Office :

70, Nagindas Master Road, Fort, Mumbai-400023, Maharashtra, India

Tel. No.:

Not Available

Mobile No.:

91-7574996300 [Mr. Rishad Kairus Dadachanji]

Fax No.:

Not Available

E-Mail :

gev.karai@schott-kaisha.com

Website :

http://www.kaishalifesciences.com

 

 

R&D Centre :

Survey No. 342/3 (77), Bharat Industrial Estate, Village Bhimpore, Nani Daman, Daman-396210, Daman and Diu (UT), India

Tel. No.:

91-260-2220924/ 25

Fax No.:

91-260-2220924

E-Mail :

info@kaishalifesciences.com

 

 

DIRECTORS

 

AS ON: 31.03.2017

 

Name :

Mr. Shapoor Pallonji Mistry

Designation :

Director

Address :

3 Et N. 32 La Reserve Bloc A, 5 Avenue Pricesse Grace 98000 Monaco Na FR

Date of Birth/Age :

06.09.1964

Date of Appointment :

06.07.2010

DIN No.:

00010114

 

 

Name :

Mr. Rishad Kairus Dadachanji

Designation :

Managing Director

Address :

603, Bhakhtavar 163/B, Lower Colaba Road, Colaba, Mumbai-400005, Maharashtra, India

Date of Birth/Age :

18.02.1991

Date of Appointment :

28.05.2014

DIN No.:

06882522

 

 

Name :

Mr. Pervin Kairus Dadachanji

Designation :

Director

Address :

603, Bakhtavar 163, Lower Colaba Road, Opp Colaba Post Office, Co, Mumbai- 400005, Maharashtra, India

Date of Appointment :

20.01.2017

DIN No.:

07712609

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

AS ON: 31.03.2016

 

Names of Shareholders

No. of Shares

 

Percentage of Holding

Kairus Dadachanji

5000

50.00

Shapoor Mistry

5000

50.00

 

 

 

Total

 

10000

100.00

 

 

AS ON: 30.09.2016

 

Equity Share Breakup

Percentage of Holding

Category

 

Promoters – Individual/ Hindu Undivided Family – Indian

100.000

 

 

Total

 

100.00

 

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer and Trader of wide range of Pharmaceutical Products from Formulation and also Research and Development (R&P) activities in Lifesciences. [Registered Activity]

 

 

Products/ Services :

ITC Code No.

 

Product Descriptions

99811121

Research & Development in Lifesciences

 

 

Brand Names :

Not Available

 

 

Agencies Held :

Not Available

 

 

Exports :

Not Divulged

 

 

Imports :

Not Divulged

 

 

Terms :

 

Selling :

Not Divulged

 

 

Purchasing :

Not Divulged

 

PRODUCTION STATUS: (NOT AVAILABLE)

 

 

GENERAL INFORMATION

 

Suppliers :

Reference:

Not Divulged

Name of the Person (Designation):

--

Contact Number:

--

Since how long known:

--

Maximum limit dealt:

--

Experience:

--

Remark

--

 

 

Customers :

 

Reference:

Not Divulged

Name of the Person (Designation):

--

Contact Number:

--

Since how long known:

--

Maximum limit dealt:

--

Experience:

--

Remark

--

 

 

No. of Employees :

Information declined by the Management

 

 

Bankers :

 

Bank Name:

Not Divulged

Branch:

Not Divulged

Person Name (with Designation):

--

Contact Number:

--

Name of Account Holder:

--

Account Number:

--

Account Since (Date/ Year of A/c Opening):

--

Average Balance Maintained (Optional):

--

Credit Facilities Enjoyed (CC/OD/Term Loan):

--

Account Operation:

--

Remarks:

--

 

 

Facilities :

---

 

 

 

Auditors :

 

Name :

Zarir Manchershaw Bhathena and Company

Chartered Accountants

Address :

4 / 9, Tata Chs, Elphinstone Bridge, Parel, Bhoiwada, Mumbai-400012, Maharashtra, India

Tel. No.:

91-22-22699399/ 22657599

Fax No.:

91-22-22691492

E-Mail :

zmbhilla@gmail.com

zmbhilla@rediffmail.com

PAN No.:

AADPB6787E

 

 

Memberships :

Not Available

 

 

Collaborators :

Not Available

 

 

Associates/Subsidiaries :

Not Available

 


 

CAPITAL STRUCTURE

 

AFTER: 30.09.2016

 

Authorised Capital : INR 50.000 Million

 

Issued, Subscribed & Paid-up Capital : INR 48.000 Million

 

 

AS ON: 31.03.2016

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

10000

Equity Shares

INR 10/- each

INR 0.100 Million

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

10000

Equity Shares

INR 10/- each

INR 0.100 Million

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in INR Million]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2016

31.03.2015

31.03.2014

I.      EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

0.100

0.100

0.100

(b) Reserves & Surplus

(9.140)

(1.384)

(0.035)

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

(9.040)

(1.284)

0.065

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) Long-term borrowings

0.160

0.367

0.000

(b) Deferred tax liabilities (Net)

0.000

0.000

0.000

(c) Other long term liabilities

0.000

0.000

0.000

(d) long-term provisions

0.000

0.000

0.000

Total Non-current Liabilities (3)

0.160

0.367

0.000

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

75.500

75.500

0.000

(b) Trade payables

0.066

0.027

0.000

(c) Other current liabilities

0.934

0.702

0.000

(d) Short-term provisions

0.288

0.307

0.009

Total Current Liabilities (4)

76.788

76.536

0.009

 

 

 

 

TOTAL

67.908

75.619

0.074

 

 

 

 

II.    ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

9.956

3.332

0.000

(ii) Intangible Assets

3.132

0.826

0.000

(iii) Capital work-in-progress

0.391

0.431

0.000

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

0.000

0.000

0.000

(c) Deferred tax assets (net)

0.000

0.000

0.000

(d)  Long-term Loan and Advances

18.356

4.639

0.000

(e) Other Non-current assets

0.000

0.000

0.000

Total Non-Current Assets

31.835

9.228

0.000

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

33.121

62.266

0.000

(b) Inventories

0.000

0.000

0.000

(c) Trade receivables

0.000

0.000

0.000

(d) Cash and cash equivalents

2.486

4.060

0.074

(e) Short-term loans and advances

0.466

0.065

0.000

(f) Other current assets

0.000

0.000

0.000

Total Current Assets

36.073

66.391

0.074

 

 

 

 

TOTAL

67.908

75.619

0.074

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

31.03.2016

31.03.2015

31.03.2014

 

SALES

 

 

 

 

 

Revenue from Operations [Net]

0.000

0.000

0.000

 

 

Other Income

4.794

2.266

0.000

 

 

TOTAL                                    

4.794

2.266

0.000

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Employees benefits expense

4.146

2.444

0.000

 

 

Other expenses

3.716

0.755

0.006

 

 

TOTAL                                    

7.862

3.199

0.006

 

 

 

 

 

 

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

(3.068)

(0.933)

(0.006)

 

 

 

 

 

Less

FINANCIAL EXPENSES                       

0.092

0.026

0.000

 

 

 

 

 

 

PROFIT/ (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION              

(3.160)

(0.959)

(0.006)

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                    

4.596

0.390

0.000

 

 

 

 

 

 

PROFIT/ (LOSS) BEFORE TAX                        

(7.756)

(1.349)

(0.006)

 

 

 

 

 

Less

TAX                                                                 

0.000

0.000

0.000

 

 

 

 

 

 

PROFIT/ (LOSS) AFTER TAX               

(7.756)

(1.349)

(0.006)

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

Capital Goods

0.391

0.431

0.000

 

TOTAL IMPORTS

0.391

0.431

0.000

 

 

 

 

 

 

Earnings/ (Loss) Per Share (INR)

(776.00)

(135.00)

(0.60)

 

 

CURRENT MATURITIES OF LONG TERM DEBT DETAILS

 

PARTICULARS

 

31.03.2016

31.03.2015

31.03.2014

Current Maturities of Long term debt

 

 

 

Vehicle Loan

0.203

0.183

0.000

 

 

 

 

Cash generated from operations

(8.218)

73.631

(0.014)

 

 

 

 

Net Cash flow from/ (used in) Operating Activities

(8.218)

73.631

(0.014)

 

 

KEY RATIOS

 

EFFICIENCY RATIOS

 

PARTICULARS

 

31.03.2016

31.03.2015

31.03.2014

Average Collection Days

(Sundry Debtors / Income * 365 Days)

0.00

0.00

0.00

 

 

 

 

Account Receivables Turnover

(Income / Sundry Debtors)

0.00

0.00

0.00

 

 

 

 

Inventory Turnover

(Operating Income / Inventories)

0.00

0.00

0.00

 

 

 

 

Asset Turnover

(Operating Income / Net Fixed Assets)

(0.23)

(0.20)

0.00

 

LEVERAGE RATIOS

 

PARTICULARS

 

31.03.2016

31.03.2015

31.03.2014

Debt Ratio

((Borrowing + Current Liabilities) / Total Assets)

1.14

1.02

0.12

 

 

 

 

Debt Equity Ratio

(Total Liability / Networth)

(8.39)

(59.23)

0.00

 

 

 

 

Current Liabilities to Networth

(Current Liabilities / Net Worth)

(8.49)

(59.61)

0.14

 

 

 

 

Fixed Assets to Networth

(Net Fixed Assets / Networth)

(1.49)

(3.57)

0.00

 

 

 

 

Interest Coverage Ratio

(PBIT / Financial Charges)

(33.35)

(35.88)

0.00

 

PROFITABILITY RATIOS

 

PARTICULARS

 

 

31.03.2016

31.03.2015

31.03.2014

Net Profit Margin

((PAT / Sales) * 100)

%

0.00

0.00

0.00

 

 

 

 

 

Return on Total Assets

((PAT / Total Assets) * 100)

%

(11.42)

(1.78)

(8.11)

 

 

 

 

 

Return on Investment (ROI)

((PAT / Networth) * 100)

%

85.80

105.06

(9.23)

 

SOLVENCY RATIOS

 

PARTICULARS

 

31.03.2016

31.03.2015

31.03.2014

Current Ratio

(Current Assets / Current Liabilities)

0.47

0.87

8.22

 

 

 

 

Quick Ratio

((Current Assets – Inventories) / Current Liabilities)

0.47

0.87

8.22

 

 

 

 

G-Score Ratio Financial

(Networth / Total Assets)

(0.13)

(0.02)

0.88

 

 

 

 

G-Score Ratio Debt

(Debts / Equity Capital)

758.63

760.50

0.00

 

 

 

 

G-Score Ratio Liquidity

(Total Current Assets / Total Current Liabilities)

0.47

0.87

8.22

Total Liability = Short-term Debt + Long-term Debt + Current Maturities of Long-term debts

 


 

 

FINANCIAL ANALYSIS

[all figures are in INR Million]

 

DEBT EQUITY RATIO

 

Particular

31.03.2014

31.03.2015

31.03.2016

 

INR In Million

INR In Million

INR In Million

Share Capital

0.100

0.100

0.100

Reserves & Surplus

(0.035)

(1.384)

(9.140)

Money received against share warrants

0.000

0.000

0.000

Share Application money pending allotment

0.000

0.000

0.000

Net worth

0.065

(1.284)

(9.040)

 

 

 

 

long-term borrowings

0.000

0.367

0.160

Short term borrowings

0.000

75.500

75.500

Current Maturities of Long term debt

0.000

0.183

0.203

Total borrowings

0.000

76.050

75.863

Debt/Equity ratio

0.000

(59.229)

(8.392)

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2014

31.03.2015

31.03.2016

 

INR In Million

INR In Million

INR In Million

Total Income

0.000

2.266

4.794

 

 

 

111.562

 

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2014

31.03.2015

31.03.2016

 

INR In Million

INR In Million

INR In Million

Total Income

0.000

2.266

4.794

Profit/ (Loss)

(0.006)

(1.349)

(7.756)

 

 

(59.53%)

(161.79%)

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check list by info agents

Available in Report

(Yes/No)

1

Year of establishment

Yes

2

Constitution of the entity -Incorporation details

Yes

3

Locality of the entity

Yes

4

Premises details

No

5

Buyer visit details

--

6

Contact numbers

Yes

7

Name of the person contacted

Yes

8

Designation of contact person

Yes

9

Promoter’s background

Yes

10

Date of Birth of Proprietor / Partners / Directors

Yes

11

Pan Card No. of Proprietor / Partners

No

12

Voter Id Card No. of Proprietor / Partners

No

13

Type of business

Yes

14

Line of Business

Yes

15

Export/import details (if applicable)

No

16

No. of employees

No

17

Details of sister concerns

No

18

Major suppliers

No

19

Major customers

No

20

Banking Details

No

21

Banking facility details

No

22

Conduct of the banking account

--

23

Financials, if provided

Yes

24

Capital in the business

Yes

25

Last accounts filed at ROC, if applicable

No

26

Turnover of firm for last three years

Yes

27

Reasons for variation <> 20%

--

28

Estimation for coming financial year

No

29

Profitability for last three years

Yes

30

Major shareholders, if available

Yes

31

External Agency Rating, if available

No

32

Litigations that the firm/promoter involved in

--

33

Market information

--

34

Payments terms

No

35

Negative Reporting by Auditors in the Annual Report

No

 

 

INDEX OF CHARGES: NO CHARGES EXISTS FOR COMPANY

 

 

UNSECURED LOANS

 

PARTICULARS

31.03.2016

(INR In Million)

31.03.2015

(INR In Million)

SHORT TERM BORROWINGS

 

 

Other Loans and advances

75.500

75.500

 

 

 

Total

 

75.500

75.500

 

 

FINANCIAL SUMMARY / HIGHLIGHTS & STATE OF THE COMPANY’S AFFAIRS:

 

During the financial year, the Company has not earned any income from operations. The Company is actively pursuing business opportunities. The Company is actively pursuing opportunities to pursue the business of carrying on research and development (R&D) activities in Lifesciences. Further, the Company wants to deliver a wide range of Pharmaceutical products from formulation development and proof of concept through its regulatory compliance followed by implementation of Quality by Design and Design of Experiments strategies.


FIXED ASSETS:

 

Tangible Assets

 

·         Land

·         Buildings

·         Plant and Equipment

·         Furniture and Fixtures

·         Air Conditioner

·         Dies and Moulds

·         Electrical Equipment

·         Computer

·         Laboratory Equipments

·         Office and Factory Equipment

·         Vehicles

 

 

 

 

 

 

 

 


 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

 

Unit

INR

US Dollar

1

INR 64.85

UK Pound

1

INR 90.58

Euro

1

INR 79.97

 

 

INFORMATION DETAILS

 

Information Gathered by :

SHA

 

 

Analysis Done by :

VIV

 

 

Report Prepared by :

IND

 


 

SCORE FACTORS

 

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

NO

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

 

 

RATING EXPLANATIONS

 

Credit Rating

Explanation

Rating Comments

A++

Minimum Risk

Business dealings permissible with minimum risk of default

A+

Low Risk

Business dealings permissible with low risk of default

A

Acceptable Risk

Business dealings permissible with moderate risk of default

B

Medium Risk

Business dealings permissible on a regular monitoring basis

C

Medium High Risk

Business dealings permissible preferably on secured basis

D

High Risk

Business dealing not recommended or on secured terms only

NB

New Business

No recommendation can be done due to business in infancy stage

NT

No Trace

No recommendation can be done as the business is not traceable

 

NB is stated where there is insufficient information to facilitate rating. However, it is not to be considered as unfavourable.

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors are as follows:

 

·         Financial condition covering various ratios

·         Company background and operations size

·         Promoters / Management background

·         Payment record

·         Litigation against the subject

·         Industry scenario / competitor analysis

·         Supplier / Customer / Banker review (wherever available)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.